Drug Topics Community Pharmacists' Report

September 4, 2012

Web Version  |   Unsubscribe  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Cystic fibrosis agent may pose cataract risk

Children with cystic fibrosis who are taking ivacaftor (Kalydeco) may be at potential risk for cataracts, according to an FDA notification issued at the end of August. » More

Continuing Education

Enhancing immunization rates

As advocates of public health through immunization, pharmacists can build public awareness, identify patient needs, and provide vaccination services.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

New anticancer agents vs. standard therapy

New anticancer agents that offer improved efficacy compared with standard therapy also increase morbidity and treatment-related mortality, according to a meta-analysis published August 20 in the Journal of Clinical Oncology. » More

Statin use may provide protection against CRC

Statins may have a protective effect against the development of colorectal cancer, according to results from a retrospective case-control study published in BMC Gastroenterology. » More

Doug Long receives NACDS' highest honor

At its Pharmacy and Technology Conference, the National Association of Chain Drug Stores presented Doug Long with the prestigious Harold W. Pratt Award. » More

TAKE OUR SURVEY

Who do you plan on voting for in the upcoming 2012 presidential election?

1. Barack Obama
2. Mitt Romney
3. I am not sure at this point.
4. I don't plan on voting because I am not excited about any of the candidates.
5. Other candidate

Respond here and see what your colleagues think, too.

Want to see the results of our last survey about immunization schedules? Click here.

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Check these out, too

NACDS Foundation Faculty Scholar class

FDA: No Revatio in children with PAH

FDA approves IBS, constipation treatment

Starting dose for gout and AHS link

Voices

DT Blog: Pharmacy's evolving options

JP at Large: Natural not always harmless

View from the Zoo: Do the time warp again

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group